Discounted Cash Flow (DCF) Analysis Unlevered

Bio-Path Holdings, Inc. (BPTH)

$4.02

+0.10 (+2.55%)
All numbers are in Millions, Currency in USD
Stock DCF: - | 4.02 | undervalue

Operating Data

Year
A/P
2017
Actual
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 0.04---------
Revenue (%)
EBITDA -6.61---------
EBITDA (%)
EBIT -7.02---------
EBIT (%)
Depreciation 0.41---------
Depreciation (%)

Balance Sheet Data

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 5.97---------
Total Cash (%)
Account Receivables ----------
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 0.05---------
Accounts Payable (%)
Capital Expenditure -0.54---------
Capital Expenditure (%)

Weighted Average Cost Of Capital

Share price $ 4.02
Beta 1.745
Diluted Shares Outstanding 6.72
Cost of Debt
Tax Rate 0.00
After-tax Cost of Debt 5.00%
Risk-Free Rate
Market Risk Premium
Cost of Equity 11.433
Total Debt -
Total Equity 27.03
Total Capital 27.03
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash

Year
A/P
2017
Actual
2018
Projected
2019
Projected
2020
Projected
2021
Projected
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Revenue 0.04---------
EBITDA -6.61---------
EBIT -7.02---------
Tax Rate 0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIAT -7.02---------
Depreciation 0.41---------
Accounts Receivable ----------
Inventories ----------
Accounts Payable ----------
Capital Expenditure -0.54-0.02--------
UFCF -7.15---------
WACC
PV UFCF ---------
SUM PV UFCF -

Terminal Value

Growth in perpetuity method:
Long-term growth rate
WACC (%) 11.43
Free cash flow (t + 1) -
Terminal Value -
Present Value of Terminal Value -

Intrinsic Value

Enterprise Value -
Net Debt -23.77
Equity Value -
Shares Outstanding 6.72
Equity Value Per Share -